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hifting the Balance Between
ortic Insufficiency and
esidual Gradients After
alloon Aortic Valvuloplasty*
alf J. Holzer, MD, MSC,
ohn P. Cheatham, MD
olumbus, Ohio
ince its introduction in the mid-1980s (1), transcatheter
herapy has replaced cardiothoracic surgery as the preferred
reatment modality in the majority of patients with congen-
tal valvular aortic stenosis. In 1990, a group from Chil-
ren’s Hospital Boston wrote an editorial in this journal
itled “Balloon Dilation of Congenital Valvular Aortic
tenosis,” emphasizing the need for long-term follow-up
ata in this group of patients (2). Now, 20 years later in this
ssue of the Journal, the same group, with David Brown as
he lead investigator, presents comprehensive long-term
ollow-up data in this patient cohort (3). This provides
mportant insight into the freedom from reintervention and
ortic valve replacement (AVR) after balloon aortic
alvuloplasty.
See page 1740
On the basis of a retrospective analysis of 509 patients,
ith a median follow-up period of 9.3 years, the investiga-
ors found that 44% of patients required some form of aortic
alve reintervention (repeat valvuloplasty, aortic valve repair,
r AVR) during the follow-up period. The survival free
rom any aortic valve intervention at 20 years was 27%, and
urvival free from AVR was 53% at 20 years. Even though
he exact causes of death were not specified in this study, the
verall survival was 88% at 20 years. All these data are
xtremely helpful in counseling patients before transcatheter
ortic valve therapies, and one probably should use a more
Editorials published in the Journal of the American College of Cardiology reflect the
iews of the authors and do not necessarily represent the views of JACC or the
merican College of Cardiology.
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he Department of Pediatrics, The Ohio State University School of Medicine,
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heatham has served as a consultant for AGA Medical, Medtronic, Inc., Numed,g
nc., Toshiba Medical, and W.L. Gore & Associates, Inc. (all monies paid to author’s
mployer).autious approach to long-term prognosis, especially when
onsidering that survival free from aortic reintervention was
nly 27% and free from AVR only 53% at 20 years.
Although not significant by multivariate analysis, the
nvestigators found by univariate analysis that survival free
rom AVR was shorter in older patients. As stated by the
nvestigators, this finding likely reflects a lower threshold to
ntervene surgically, combined with the fact that operators
ay be more easily persuaded to upsize the balloon to
chieve a better gradient reduction, because of the knowl-
dge that surgery with adequate results is much more readily
chievable than in neonates.
Not surprisingly, the investigators found that lower post-
ilation aortic valve gradients and a lower grade of post-
ilation aortic insufficiency (AI) were associated with a
onger freedom from AVR. While these data are important,
ithout clear thresholds, it does not help the intervention-
list in deciding when a more aggressive approach may be
arranted. Increasing the balloon size may lead to lower
esidual gradients and, therefore, theoretically to improved
reedom from AVR. However, at the same time, an in-
reased amount of aortic regurgitation may completely
egate the achieved benefit, which has been the main reason
or operators being reluctant to push for a more aggressive
radient reduction.
The difficulty faced in the catheterization laboratory is
sually the decision on when to upsize (or not to upsize) the
alloon, especially in those patients with borderline residual
radients of 30 to 40 mm Hg. When gradients are higher,
specially in older patients, one very rarely hesitates to
psize the balloon when the degree of AI is only mild or
ess. However, if residual gradients are 30 mm Hg, there
s very little to be gained in upsizing the balloon any further.
ompounding this dilemma is the fact that balloons usually
re only available in 1- to 2-mm increments, so that a single
psized balloon in an infant from a 10- to an 11-mm
epresents a 10% increase, while upsizing a balloon from 19
o 20 mm is only a 5% increase. To help answer these
uestions and to provide interventionalists with a better
efined guide, the investigators compared freedom from
VR for different combinations of AI and residual aortic
tenosis. For this purpose, patients were divided into those
ith residual gradients above and below 35 mm Hg in
ombination with different degrees of aortic regurgitation
none-trivial, mild, or moderate-severe). The finding that
reedom from AVR was not any worse (and potentially
etter) in patients with residual gradients of 35 mm Hg
nd moderate or severe AI compared with patients with
esidual gradients of 35 mm Hg and mild AI should help
n persuading operators to upsize the balloon if the gradient
s 35 to 40 mm Hg with just mild AI, rather than a more
onservative approach for fear of creating more AI. This is
specially true as the long-term outcome seems notably
etter if the degree of AI were to remain mild, but the
radient would drop to 35 mm Hg. As such, within the
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November 16, 2010:1750–1 Desirable Outcome After BAVorderline gradients of 30 to 40 mm Hg, further gradient
eduction may be more important than the degree of AI in
erms of long-term outcome. Although the investigators
cknowledge that these data were not adjusted for age, they
re the first data of their kind that give operators a
uantitative guideline on when to continue with balloon
alvuloplasty using a larger balloon size and when to stop.
These data may also influence the clinical follow-up of
atients after AVR. Patients with a mild to moderate degree
f AI and moderate residual stenosis (40 mm Hg) are
ften not considered for repeat balloon aortic valvuloplasty,
ecause of the concern of increasing AI, and are instead
estricted from exercise because of the degree of residual AS
nd concern about sudden cardiac death, which is based on
eneral consensus statements, such as the 36th Bethesda
onference and other recommendations endorsed by the
merican College of Cardiology and the American Heart
ssociation, but without any true evidence-based studies
4). However, with the data suggesting that moderate
esidual aortic valve stenosis may be worse than moderate
I in terms of survival free from AVR, it raises the question
f whether restricting a patient from exercise because of
oderate residual AS may in fact be a valid reason to seek
more aggressive transcatheter approach. If a patient is old
nough to have all surgical options available at a fairly low
isk, one could argue that it would be important to achieve
n adequate gradient reduction that not only puts the
atient into a better category with regard to long-term
urvival free from AVR but that may also allow the
hysician to remove any exercise restriction that was pre-
cribed. This may lead to a repeat transcatheter interven-
ion, even in the presence of mild to moderate aortic
egurgitation, knowing that more definitive surgical therapy
s available if a satisfactory transcatheter result cannot be
chieved. The residual aortic valve gradient appears to be
uch more important in terms of freedom from AVR than
reviously anticipated. Many recent publications still state
hat “valvuloplasty is not recommended for asymptomatic
atients with a peak-to-peak gradients 50 mm Hg” (5).
lthough this may still hold true for infants and smaller
hildren with limited surgical options, the data in this
resent study do not support a conservative approach for
his type of gradient in older children or young adults.
However, although these data are uniquely important,
here are inherent limitations to this study. As acknowl-
dged by the investigators, the main outcome variable,
K
hVR, may not necessarily be a good descriptor of aortic
alve function and may instead reflect a very variable referral
attern of individual cardiologists. As such, the clinical
tatus, electrocardiographic changes, valve morphology and
unction, and the specific indications for surgical valve
eplacement may have been quite variable in this cohort.
his is an inherent problem of retrospective studies, and the
nvestigators concede that this could only be overcome with
rospective data collection.
In conclusion, Brown et al. (3) have provided excellent
ata on the long-term outcomes in patients who have
ndergone balloon aortic valvuloplasty. These data will be
xtremely helpful in counseling patients about the not
nsignificant need for surgical AVR over a 20-year period
nd of practical importance in the catheterization laboratory
hen contemplating upsizing of the balloon. The data
mphasize the importance of adequate gradient reduction
or a satisfactory long-term outcome. Now, all we have to do
s reconcile these data with the emerging transcatheter
ortic valve implantation indications for aortic valve steno-
is, again illustrating that aortic valve disease, whether
ongenital or acquired, is not a simple matter!
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